Brown fat can reduce obesity through the dissipation of calories as heat. Control of thermogenic gene expression occurs via the induction of various coactivators, most notably PGC-1a. In contrast, the transcription factor partner(s) of these cofactors are poorly described. Here, we identify interferon regulatory factor 4 (IRF4) as a dominant transcriptional effector of thermogenesis. IRF4 is induced by cold and cAMP in adipocytes and is sufficient to promote increased thermogenic gene expression, energy expenditure, and cold tolerance. Conversely, knockout of IRF4 in UCP1 + cells causes reduced thermogenic gene expression and energy expenditure, obesity, and cold intolerance. IRF4 also induces the expression of PGC-1a and PRDM16 and interacts with PGC-1a, driving Ucp1 expression. Finally, cold, b-agonists, or forced expression of PGC-1a are unable to cause thermogenic gene expression in the absence of IRF4. These studies establish IRF4 as a transcriptional driver of a program of thermogenic gene expression and energy expenditure.
INTRODUCTION
Although many creatures can produce heat, only eutherian mammals possess brown adipocytes, specialized cells that use uncoupling protein 1 (UCP1) to dissociate O 2 consumption from ATP synthesis. This highly thermogenic process consumes large amounts of substrate (primarily fatty acids but also glucose) and is activated by cold exposure, catecholamines, and other stimuli (Villarroya and Vidal-Puig, 2013) . Two different UCP1 + cell types have been described, so-called ''classic'' brown adipocytes, which are present at all times in the interscapular region of rodents and a ''recruitable'' cell called the beige adipocyte that develops within specific white adipose depots when environmental conditions demand it . These two UCP1 + cell types derive from different embryological origins, and they express overlapping but distinct gene expression programs Wu et al., 2012) . The study of human brown fat has undergone a dramatic renaissance with the recent discovery that adults possess significant quantities of this tissue (Cypess et al., 2009; van Marken Lichtenbelt et al., 2009; Virtanen et al., 2009) , opening the door for therapeutic manipulation of these cells in diabetes and obesity.
At the transcriptional level, most attention has fallen on various cofactors, which lack DNA binding domains and thus must act by docking on bona fide transcription factors. Among the best studied of these are PGC-1a and Prdm16, the latter of which acts through the transcription factors C/EBPb, PPARg, and possibly others to promote brown and beige adipocyte identity (Kajimura et al., , 2009 Seale et al., 2007) . PGC-1a has been shown to coactivate PPARg and PPARa to promote brown fat differentiation and fatty acid oxidation respectively; it drives mitochondrial biogenesis, at least in part, via its actions on ERRa (Wu and Boss, 2007) . It is less clear, however, how the thermogenic gene expression program is coactivated by PGC1a. For example, mice lacking ERRa have defects in mitochondrial number and function but still induce Ucp1 expression appropriately when exposed to cold (Villena et al., 2007) . Similarly, PPARa null mice display defective fatty acid oxidation but normal thermogenic gene expression, including Ucp1 (Xue et al., 2005) .
We have previously identified interferon regulatory factor 4 (IRF4) as an important regulator of adipogenesis and adipose lipid handling (Eguchi et al., 2008 (Eguchi et al., , 2011 . IRF4 expression is induced by fasting in adipocytes via FoxO1 and is repressed by insulin. Animals that lack IRF4 in adipose tissue are obese and insulin resistant and are unable to fully mobilize lipid stores in the face of catecholamine treatment or prolonged fasting (Eguchi et al., 2011) . Of note, these mice are also cold intolerant, a phenotype ascribed at the time to reduced fatty acid substrate required to fuel thermogenesis. Interestingly, however, we also noted that some thermogenic gene expression, including Ucp1, was reduced in the interscapular brown adipose tissue (BAT) of these animals. This led to the suggestion that, in addition to serving as a key regulator of lipolysis in both brown and white adipose tissues, IRF4 might also play a direct thermogenic role in the latter.
Here, we show that IRF4 is transcriptionally regulated by cold and cAMP in murine and human BAT prior to the induction of Ucp1 and that mice that overexpress IRF4 transgenically in BAT display enhanced thermogenic gene expression, energy expenditure, and cold tolerance. Conversely, mice lacking IRF4 specifically in UCP1 + cells are obese and insulin resistant and display reduced thermogenic gene expression, cold tolerance, and energy expenditure. Importantly, IRF4 induces the expression of both Ppargc1a and Prdm16 and physically interacts with PGC-1a to induce Ucp1 expression. Finally, cold, catecholamines, and forced expression of PGC-1a are unable to induce thermogenic gene expression in the absence of IRF4. (A and B) qPCR and western blotting were performed on mRNA and protein from fat depots of C57BL/6 mice at room temperature (RT) or exposed to 4 C for 6 hr.
(C) qPCR was performed on mRNA from BAT of C57BL/6 mice exposed to 4 C for the indicated lengths of time (n = 5).
(D) Mice were treated with CL316,243 for 6 hr prior to tissue harvest and qPCR.
(E) SVF from inguinal fat was differentiated into adipocytes ex vivo, treated with Forskolin for 4 hr, and then analyzed by qPCR.
(F) 3T3-F442A adipocytes were differentiated and cultured at 37 C or 30 C for 10 days followed by harvest and qPCR.
(G) SVF from superficial and deep neck adipose tissue depots from four human subjects were differentiated into mature adipocytes and treated for 4 hr with 500 mM dibutyryl-cAMP. For all parts, *p < 0.05, expressed as mean ± SEM.
Taken together, these studies demonstrate that IRF4 acts as a dominant transcriptional regulator of thermogenesis via genetic and physical interactions with PGC-1a.
RESULTS

Irf4 Expression Is Induced in Brown
Adipocytes by Cold and cAMP Fasting induces Irf4 in both WAT and BAT (Eguchi et al., 2011) , and we wondered if cold exposure might have a similar effect. This proved to be the case, as 6 hr at 4 C increased both mRNA and protein levels of IRF4 in classical interscapular brown fat as well as in inguinal and epididymal white fat ( Figures 1A and 1B ). Time course analysis shows that this effect occurs within an hour of cold exposure, coincident with the induction of Ppargc1a and prior to Ucp1 ( Figure 1C ). Irf4 mRNA was also induced after the administration of the b3-agonist CL-316,243 ( Figure 1D ). To test whether these effects are cell autonomous, we harvested the stromal-vascular fraction (SVF) from the brown fat pads of newborn mice and differentiated them ex vivo; treatment of these cells with forskolin caused a significant elevation in Irf4 mRNA levels ( Figure 1E ). Recently, cultured 3T3-F442A adipocytes were shown to induce a thermogenic gene expression program when exposed directly to 30 C (Ye et al., 2013) . We tested whether Irf4 expression is also sensitive to this perturbation and found a modest but significant induction by cold even in these isolated cells ( Figure 1F ), suggesting the involvement of cell autonomous mechanisms that do not require catecholamine signaling. UCP1 + adipocytes have now been unequivocally identified in adult humans (Cypess et al., 2009; van Marken Lichtenbelt et al., 2009; Virtanen et al., 2009) . There is still ambiguity over whether these cells correspond to murine brown or beige fat, with one study suggesting that more superficial neck deposits are similar to beige, whereas deeper depots correspond to classic brown fat (Cypess et al., 2013) . We found that cAMP treatment dramatically induced Irf4 mRNA expression in adipocytes derived from both deep and superficial human depots ( Figure 1G ).
Targeted Expression of IRF4 Causes Enhanced Energy Expenditure and Leanness
Having established that IRF4 expression is elevated in the BAT and WAT of cold-exposed animals, we asked whether IRF4 is sufficient to promote thermogenesis. To this end, we developed a line of knockin mice in which the IRF4 cDNA was inserted downstream of the ROSA26 promoter and a loxP-Stop-loxP cassette (R26-LSL-IRF4; Figure S1A available online). Crossing these mice to Ucp1-Cre mice would then enable targeted overexpression in brown adipocytes. Unfortunately, the available Ucp1-promoter driven Cre line (Guerra et al., 2001 ) has problems with both specificity and recombination efficiency. We thus generated a Ucp1-Cre line using a BAC transgenic approach. By inserting the Cre recombinase cassette into the starting ATG of Ucp1 within a large bacterial artificial chromosome (Figure S1B ), we ensured that the majority of the key regulatory elements would be in their native context. At room temperature, these mice express Cre specifically in the interscapular brown fat ( Figure S1C ). Cold exposure induces Cre expression in inguinal and epididymal WAT in a time-dependent manner, consistent with the onset of browning ( Figure S1D ). Importantly, these mice do not have any obvious metabolic phenotype (Figures S1E , S1F, and S2A). Mice that carry both the Ucp1-Cre and R26-LSL-IRF4 transgenes (hereafter designated as BAT IRF4 overexpressors, or BATI4OE) exhibit moderate (5-103) overexpression of IRF4 in BAT (Figures 2A and 2B ), in the range of the induction seen following exposure to cold or b-agonist. No overexpression is seen in inguinal or epididymal depots at room temperature. BATI4OE mice display significantly reduced body weight and fat mass on both chow ( Figures S2A and S2B ) and high-fat diets (HFDs) (Figures 2C and 2D ). Both inguinal and epididymal depots are smaller in BATI4OE mice and their adipocytes show less hypertrophy on an HFD than those of control mice ( Figures 2E,  2F , and S2C). Food intake did not differ between the genotypes ( Figure 2G ), but BATI4OE mice had enhanced energy expenditure ( Figures 2H and 2I) ; physical activity was unchanged ( Figure S2D ). In addition, we assessed the effect of IRF4 overexpression in BAT on glucose homeostasis and found that overexpressor mice have improved glucose and insulin tolerance testing relative to controls on an HFD ( Figures S2E and S2F ).
IRF4 Expression Is Sufficient to Cause Enhanced
Thermogenesis in BAT BATI4OE mice have smaller brown adipose depots (Figures S2C and 3A) and reduced lipid stores in BAT at both room temperature and 4 C ( Figure 3B ). This phenotypic change is accompanied by increased expression of key thermogenic genes (e.g., Ucp1, Prdm16, and Ppargc1a) ( Figures 3C and 3D) . Fatty acid oxidation genes (e.g., Ppara, Cpt1b) were also induced, consistent with a trend toward increased palmitate oxidation in BATI4OE brown adipocytes tested ex vivo ( Figure S2G ). No change was seen in the expression of genes encoding mitochondrial proteins ( Figure 3C ), although some changes are seen in the mitochondrial protein levels themselves ( Figure S2H ). Isolated mitochondria from the BAT of BATI4OE mice display increased uncoupled respiration ( Figure 3E ). General adipose markers are unaffected in these mice, as were lipolysis genes ( Figure 3F ), consistent with unaltered lipolysis in brown adipocytes ex vivo and BATI4OE mice in vivo ( Figures S2I and S2J) . Interestingly, lipogenesis was significantly reduced in brown adipocytes from BATI4OE mice ( Figure S2K ), although genes like Fasn, Srebf, and Scd1 are unaltered ( Figure 3F ). Consistent with the changes in thermogenic gene expression, BATI4OE mice are modestly but significantly better able to defend their body temperature during an acute cold stress ( Figure 3G ).
We also assessed whether overexpression of IRF4 could affect the browning of white adipose depots. As expected, BATI4OE mice do not show elevated IRF4 levels in inguinal WAT at room temperature, as there is minimal Ucp1 expression in that condition and thus no recombination. Exposure to cold for 6 days increased Irf4 expression in both control and BATI4OE mice such that the final levels were equivalent in the two lines. Consistent with this, we saw no difference in thermogenic gene expression or in the histological appearance of inguinal fat (Figures S3A and S3B) . In epididymal fat, however, we did see increased Irf4 expression in BATI4OE mice, accompanied by increased thermogenic gene expression and a histological pattern consistent with enhanced browning (Figures S3C and S3D ).
Loss of IRF4 in Brown Fat Causes Reduced Energy Expenditure and Predisposes to Obesity
It is well established that obese animals and humans show deficiencies in BAT content and function (Ricquier et al., 1986; Saito et al., 2009; Tokuyama and Himms-Hagen, 1986; van Marken Lichtenbelt et al., 2009; Vijgen et al., 2011; Virtanen et al., 2009) , and consistent with this, we see reduced Irf4 expression in the interscapular BAT of high-fat fed mice as well as in two genetic models of obesity (ob/ob and db/db) ( Figure 4A ).
Of course this association does not prove causality, so we generated animals lacking IRF4 specifically in BAT by crossing our Ucp1-Cre line to Irf4 flox/flox mice (Klein et al., 2006) . The resulting Irf4 flox/flox ;Cre + animals (henceforth designated as BAT IRF4 knockout, or BATI4KO) have remarkably little IRF4 mRNA or protein left in the interscapular BAT at room temperature (Figures 4B and 4C) , while other tissues, such as WAT and spleen, show no change. Resident macrophages and T cells, which express high levels of IRF4 but do not express Ucp1, likely account for the small amount of residual IRF4 seen in BAT. On chow diet, male BATI4KO mice display a tendency toward higher body weight ( Figure S4A ) and have a small but significant increase in fat mass ( Figure S4B ). On an HFD, the BATI4KO mice clearly have elevated body weight and adiposity (Figures 4D and 4E 4G , and S4C). The cause of the increased adiposity seen in BATI4KO mice was not increased food intake, as this did not differ between these mice and their controls ( Figure 4H ). Rather, large reductions were seen in both oxygen consumption and (legend continued on next page) CO 2 production (Figures 4I and 4J) without altered physical activity ( Figure S4D ).
As would be predicted from their elevated body weight, BATI4KO mice show worsened glucose and insulin tolerance ( Figures S4E and S4F ). To determine whether this could be fully ascribed to obesity, we repeated the glucose and insulin tolerance tests on mice exposed to an HFD for only 4 weeks, a time point prior to the divergence in body weight. These mice still showed significant glucose and insulin intolerance under these conditions ( Figures S4G and S4H ), indicating that increased body weight is not the primary driver of the metabolic defect. Although some BATI4KO mice appeared to be longer than their control littermates, this was not significant between the groups as a whole (n = 8-11).
IRF4 Is Required for Normal Thermogenesis and Mitochondrial Function in BAT
Reduced energy expenditure, obesity, and dysglycemia are all hallmarks of deficient brown adipose function and suggest a defect in thermogenic capacity. The interscapular brown adipose depot from BATI4KO mice was grossly larger and showed hypertrophic cells with increased lipid content at room temperature (Figures 5A, 5B, and S4C). At 4 C, both genotypes showed reduced lipid in BAT, although a significant difference was still noted ( Figure 5B ). This was accompanied by a clear reduction in the expression of genes associated with thermogenesis, electron transport, and fatty acid oxidation ( Figures 5C and 5D ). As predicted by the gene expression changes, palmitate oxidation in BATI4KO cells was significantly reduced ( Figure S5A ). In accordance with our prior work (Eguchi et al., 2011) , we saw significant reductions in lipolytic gene expression, accompanied by diminished lipolytic activity ex vivo and in vivo (Figures S5B and S5C) . As was seen in the overexpressor mice, lipogenic activity was altered even though lipogenic gene expression was not (Figures 5E and S5D) . BATI4KO mice show reduced mitochondrial respiration (Figures 5F and 5G) and gene expression (Figures 5C and S5E) . At the ultrastructural level, however, the mitochondria of BATI4KO mice appear indistinguishable from their controls, both in terms of overall number and in the density of cristae ( Figures S5F-S5H ). We next exposed BATI4KO and control mice to 4 C and measured body temperature, to assess the physiological importance of these defects. As predicted, BATI4KO mice were less able to defend their body temperature in the face of acute cold stress ( Figure 5H ).
We also wished to assess the requirement for IRF4 in the browning of white fat. We were concerned that our system is not optimized to answer this question, because Cre-mediated recombination will not occur until after cold drives the differentiation of these cells . Despite this caveat, however, BATI4KO mice exposed to 4 C for 6 days display reduced thermogenic and mitochondrial gene expression in their inguinal WAT relative to control mice ( Figure S6A ). This was consistent with the cold-dependent appearance of small, multilocular UCP1 + cells in control, but not BATI4KO mice (Figure S6B) . No change was seen in the histological appearance or gene expression pattern of epididymal fat in these mice ( Figures  S6C and S6D ).
Thermogenic Gene Expression Cannot Be Induced by Cold or b-Agonists in the Absence of IRF4 Having determined that IRF4 is required for basal thermogenic gene expression in brown and beige adipocytes, we next asked whether this program could still be provoked in the absence of IRF4. We first assessed this in cold-exposed animals, showing that many thermogenic genes such as Ucp1, Dio2, and Ppargc1a become induced in the interscapular BAT of floxed control mice, but not BATI4KO mice ( Figure 6A ). Similarly, the CL-316,243 induces a broad array of genes that promote thermogenesis, fatty acid oxidation, and lipolysis in control mice, while BATI4KO mice do not recapitulate this effect ( Figure 6B ).
PGC-1a and IRF4 Interact Genetically, Physically, and Functionally IRF4 is induced in BAT contemporaneously with PGC-1a (Figure 1C) and is required for the full expression of PGC-1a in both the basal and stimulated states ( Figures 5C, 6A , and 6B). We next asked whether the converse is also true; is PGC-1a required for Irf4 expression? We first looked at the BAT of mice lacking Ppargc1a in adipose tissue (Kleiner et al., 2012) and saw that, in fact, Irf4 mRNA levels were $1/3 of those seen in wild-type (WT) control animals ( Figure S7A ). Furthermore, we took SVF cells from the inguinal fat of these mice and differentiated them ex vivo; treatment with forskolin caused a significant induction of Irf4 mRNA in wild-type cells that was severely blunted in cells lacking PGC-1a ( Figure S7B ). Together, these data suggest that PGC-1a and IRF4 induce each other's expression in a mutually reinforcing loop. We also asked whether IRF4 and PGC-1a interact physically. The phenomenon in which a transcription factor induces the expression of a coactivator and then interacts with that factor to regulate downstream gene expression is considered a form of feed-forward regulation (Alon, 2007; Wu et al., 1999) . In a coimmunoprecipitation assay in vitro, we found that PGC-1a interacts strongly with IRF4 ( Figure 7A ). This could be recapitulated in isolated brown adipocytes from cold-exposed mice, demonstrating that the interaction occurs at normal levels of these two proteins ( Figure 7B ). Furthermore, the interaction is direct, as it occurs even in a GST pull-down assay in vitro (Figure 7C ). Nuclear receptors, like PPARg and ERRa, interact with PGC-1a via LXXLL motifs found in the N-terminal half of the molecule (Huss et al., 2002; Schreiber et al., 2003) . We used various truncation mutants of PGC-1a to show that IRF4 docks on the same part of the molecule (Figures S7C and S7D ).
(G) Food intake was measured daily after 3 weeks on HFD (n = 8), and cumulative food intake was calculated after 3 days. (H and I) O 2 consumption and CO 2 production rates of BATI4OE and WT littermates were measured by indirect calorimetry using CLAMS after 4 weeks on HFD (n = 8; *p < 0.0001 for both). See also Figures S1 and S2 . (C) Thermogenic, mitochondrial and fatty acid oxidation gene expression in BAT. RNA was harvested from BAT of BATI4OE and control littermates after 28 weeks on HFD at 23 C. Gene expression was measured using qPCR. Data are normalized to 36B4 and expressed as mean ± SEM (n = 3-5, *p < 0.05).
(D) Western blot analysis of protein in BAT of mice from (C).
(legend continued on next page)
Specifically, deletion of the second and third LXXLL motifs of PGC-1a completely blocks the interaction with IRF4 ( Figure S7E ). IRF4, like other members of the IRF family, has a large C-terminal region used for protein-protein interactions (IAD), such as with PU.1 or other IRFs ( Figure S7F ) (Honda and Taniguchi, 2006) . Deletion of the IRF4 DBD does not disrupt the interaction with PGC-1a, but removal of the IAD does ( Figure S7G ). We also examined the 5 0 flanking region of the Ucp1 gene to determine whether IRF4 might serve as a direct transcriptional regulator. Computational analysis identified a consensus interferon-stimulated response element (ISRE) located 1,251 base pairs upstream of the transcriptional start site. A Ucp1 promoter-luciferase construct transfected into 293 cells could be activated independently by IRF4 and by PGC-1a and the two together caused an additive induction ( Figure 7D) . A smaller construct (À1,727) that still contains the ISRE showed even more impressive activation by PGC-1a and IRF4, suggesting distal negative regulatory elements. However, deletion of the ISRE abolished the induction of luciferase expression by IRF4, PGC-1a, or both. Similar results were obtained when primary BAT cells were used ( Figure S7H ). IRF4 binds to this site on the Ucp1 promoter in BAT, as shown by chromatin immunoprecipitation ( Figure 7E ).
Finally, we forced overexpression of PGC-1a directly in the inguinal white fat of mice using adenoviral delivery. Even the modest level of overexpression achieved (z50% increase over basal) was sufficient to induce thermogenic gene expression in this depot in wild-type mice. BATI4KO mice, however, did not show this effect, demonstrating definitively that PGC-1a is not thermogenic in the absence of IRF4 ( Figure 7F ). Our data thus strongly suggest a model in which PGC-1a and IRF4 induce each other's expression and then interact physically to fully activate Ucp1 ( Figure 7G ).
DISCUSSION
Adaptive (nonshivering) thermogenesis relies upon the successful execution of a defined program of gene expression in response to ambient conditions, centered on Ucp1. In general, transcription requires the concerted actions of sequence-specific DNA binding proteins as well as a large number of cofactors, which do not themselves bind to DNA. These cofactors can activate or repress transcription, depending upon their ability to recruit specific chromatin-modifying enzymes to the locus being regulated. Interestingly, while a few sequence-specific transcription factors that play a role in brown fat differentiation and function have been identified, such as PPARa, PPARg, C/EBPb, EBF2, and ERRa, a much larger number of cofactors have been described (Kajimura et al., 2010; Rajakumari et al., 2013) .
These include pocket proteins like pRb and p107, but also SRC-1, SRC-2, SRC-3, TRIP-Br2, RIP140, and most notably, PRDM16 and PGC-1a (Kajimura et al., 2010; Liew et al., 2013; Puigserver and Spiegelman, 2003) . The challenge, then, has been to identify the transcriptional partners through which these cofactors act to promote their activities.
Most of the published data on transcription and brown fat relate to the processes of development and the establishment of brown fat identity. Our work focuses instead on the transcriptional basis for thermogenic function in already differentiated brown and beige adipocytes. Specifically, the use of Ucp1-Cre mice to target ablation or overexpression of IRF4 requires that brown fat identity be already established. We have previously shown that IRF4 is moderately antiadipogenic (Eguchi et al., 2008) ; the actions we have focused on here and in our prior work in which we knocked out Irf4 using an adiponectin-Cre deletor strain (Eguchi et al., 2011) are studies of adipocyte physiology, not specification or differentiation.
Brown and beige adipocytes are defined in part by their rich complement of mitochondria. PGC-1a is a major driver of mitochondrial biogenesis and function, subserving this function through interactions with ERRa and NRF-2 (Giguè re, 2008). IRF4 does not promote mitochondrial gene expression when overexpressed in brown adipocytes, although we do see significantly reduced gene expression when IRF4 is ablated, associated with reduced oxygen consumption. Even in this condition, however, there is no change in mitochondrial number or appearance. This suggests that the interaction of PGC-1a and IRF4 to promote thermogenesis is distinct from an effect on mitochondrial biogenesis. In contrast, IRF4 is both necessary and sufficient to promote the fatty acid oxidation gene program, including expression of the dominant transcription factor of that process, PPARa.
We previously showed that loss of IRF4 in all fat (using the adiponectin-Cre line) diminishes isoproterenol-stimulated glycerol release by 30%-50% (Eguchi et al., 2011) , an effect seen both ex vivo and in vivo. Somewhat surprisingly, in the present work, loss of IRF4 restricted to Ucp1 + cells has a quantitatively similar effect on lipolysis ( Figures S5B and S5C ). Taken at face value, this suggests that BAT is the dominant source of liberated glycerol after a catecholamine challenge, despite the fact that BAT represents a small percentage of total fat mass. In fact, this may be a reasonable expectation, given that the b-adrenergic receptors Adrb1, Adrb2, and Adrb3 are all expressed to a greater degree in BAT than in WAT (http://biogps.org); isoproterenol is a nonselective agonist of all three subtypes. Thus, BAT may be poised to transduce the catecholaminergic signal much more rapidly than WAT, and elevated glycerol levels in the first few hours after adrenergic stimulation may derive almost entirely (E) Continuous measurement of oxygen consumption rate (OCR) in isolated mitochondria from BAT of BATI4OE and control mice on chow. Oxygen consumption was performed under basal conditions, following the addition of oligomycin (14 mM), the pharmacological uncoupler FCCP (10 mM) or the Complex III and I inhibitor antimycin A and rotenone (4 mM each) (n = 10-12, *p < 0.05).
(F) Lipid handling and general adipose marker gene expression in BAT. RNA was harvested from BAT of BATI4OE and control littermates after 28 weeks on HFD at 23 C. Gene expression was measured using qPCR. Data are normalized to 36B4 and expressed as mean ± SEM (n = 3-5, *p < 0.05).
(G) Rectal temperature of control and BATI4OE mice during acute cold exposure (4 C). Results are expressed as mean ± SEM (n = 6 mice per group, *p < 0.05 for AUC). See also Figure S3 . (legend continued on next page) from brown adipocytes. Perhaps depletion of BAT lipid stores might occur with longer periods of fasting, cold, or adrenergic agonist administration, allowing WAT to become the dominant source of lipolytic products. Testing this hypothesis will require careful tracer studies to identify the source of serum glycerol after a lipolytic provocation. Our previous work also demonstrated that IRF4 was antilipogenic in white fat, such that loss of IRF4 in white adipocytes increased expression of such key lipid synthesis genes as Scd1, Fasn, and Srebf1. Concordant with this, loss of IRF4 enhanced 14 C-glucose incorporation into lipid and add-back of IRF4 repressed this (Eguchi et al., 2011 ). In the current study, we find that loss of IRF4 in brown fat also increases lipid synthesis from glucose and overexpression inhibits it. However, we see no concomitant change in lipogenic expression in either the gain-of-function or loss-of-function models to explain this. Possibly there are differences in levels of lipogenic enzyme protein or activity, or perhaps IRF4 is exerting its primary effects at the level of lipolysis and fatty acid oxidation, and the changes in lipid synthesis simply reflect altered substrate availability.
IRF4, unlike many other IRFs, is regulated strongly at the transcriptional level. In our previous work, we demonstrated that expression of Irf4 mRNA is induced by fasting in both brown and white adipocytes (Eguchi et al., 2011) . This effect is due to the drop in insulin levels that occurs in the fasted state, allowing FoxO1 to remain in the nucleus, where it drives the Irf4 promoter. Interestingly, Ortega-Molina et al. (2012) recently showed that mice overexpressing Pten have enhanced FoxO1 activity and are lean with increased Ucp1 and Ppargc1a expression. Could FoxO1 be activated by cold and thus serve as the upstream effector of IRF4 expression in BAT? A recent report demonstrates that FoxO1 is induced by 24 hr of cold exposure in rat muscle, with a subsequent increase in proteolysis (Manfredi et al., 2013) . Thus, FoxO1 is an excellent candidate for a coldinducible activator of IRF4 and subsequent thermogenesis. Other factors may also be at play, such as CREB, which mediates many of the transcriptional effects of cAMP (Altarejos and Montminy, 2011) . Interestingly, a recent paper suggests that IRF4 acts upstream of CREB, at least in cardiac muscle .
IRF4 plays a wide variety of roles in the immune system, including critical functions in macrophage polarization (Eguchi et al., 2013; Satoh et al., 2010) , plasma cell differentiation (Klein et al., 2006; Sciammas et al., 2006) , regulatory T cell function (Cretney et al., 2011; Zheng et al., 2009) , and the differentiation of CD4 + and CD8 + T cells (Brü stle et al., 2007; Kwon et al., 2009; Man et al., 2013; Raczkowski et al., 2013; Staudt et al., 2010; Yao et al., 2013) . By and large, these studies have focused on a limited subset of IRF4 target genes that control immune cell differentiation, without considering a possible role for IRF4 as a regulator of energy metabolism, despite a longstanding appreciation of the enormous energy requirements inherent in mounting a coherent immune response (Odegaard and Chawla, 2013) . One recent paper, however, did report that energy metabolism genes were direct targets of IRF4 in cytotoxic CD8
+ T cells and even suggested that IRF4 ablation in these cells resulted in a reduced oxygen consumption rate (Man et al., 2013) , consistent with what we find in brown adipose tissue. There has not been significant investigation into the role of PGC-1a in lymphocyte biology, although it is expressed in these cells (http://biogps.org), and one study does suggest a possible role for PGC-1a in regulating intralymphocyte antioxidant levels after exercise (Ferrer et al., 2009) . In macrophages, the related coactivator PGC-1b is induced by Th2 cytokines like IL-4, promoting oxidative metabolism and reduced inflammatory gene expression. It is unknown whether IRF4 interacts with PGC-1b, although this isoform does possess similar LXXLL domains as PGC-1a and is able to coactivate nuclear receptors (Meirhaeghe et al., 2003) . Our results demonstrate that IRF4, alone or in combination with PGC-1a, is a transcriptional regulator of cellular metabolism and support deeper investigation of this as a possible mechanism by which it acts in immune cells. Transcriptional regulation of the Ucp1 gene has been studied extensively. Early studies by Kozak et al. (1994) and Larose et al. (1996) focused on an $200 bp region located $2.5 kb upstream of the Ucp1 transcriptional start site. This area, originally defined by DNase I hypersensitivity, contains binding sites for transcription factors that mediate brown fat specification (PPARg, EBF2) as well as cold and norepinephrine-induced thermogenesis (e.g., TR, CREB) (Boyer and Kozak, 1991; Kozak et al., 1994; Larose et al., 1996; Rajakumari et al., 2013) . Here, we isolate an interferon-stimulated response element (ISRE) mediating at least part of the IRF4 response that is separate from this narrowly defined enhancer. This region falls outside of all previously identified 5 0 flanking DNase hypersensitivity regions (Boyer and Kozak, 1991) , but it should be noted that more recent studies from the mouse ENCODE consortium indicate that the entire 10 kb region proximal to the Ucp1 TSS is heavily decorated by H3K4me1, H3K4me3, and H3K27ac marks in brown adipose tissue (https://genome.ucsc.edu/ENCODE/dataSummaryMouse. html). This indicates that a much larger region of this locus is characterized by open chromatin than has previously been appreciated.
Finally, it is worth remembering that nonshivering thermogenesis requires the coordinated activities of several different tissues. Cold must be sensed and signals sent via the sympathetic nervous system to release catecholamines, which activate b-adrenergic receptors in brown fat. Lipolysis in white fat must also occur to generate the fatty acid substrate required to fuel mitochondrial activity. Alternatively activated (so-called M2) macrophages have recently been proposed to participate in thermogenesis via their own elaboration of (H) Food intake was measured daily after 20 weeks on HFD (n = 8), and cumulative food intake was calculated after 3 days. (I and J) O 2 consumption and CO 2 production rates of BATI4KO and control littermates were measured by indirect calorimetry using CLAMS after 22 weeks on HFD (n = 8; *p < 0.0001 for both). See also Figure S4 . (legend continued on next page)
catecholamines (Nguyen et al., 2011) . IRF4 has now been shown to be a key regulator of all of these processes: it is required for lipolysis in white fat (Eguchi et al., 2011) and for M2 polarization of macrophages (Eguchi et al., 2013; Satoh et al., 2010) , and we now show that there is a direct effect of IRF4 on thermogenic gene expression in BAT. Taken together, these data establish IRF4 as a central actor in adaptive thermogenesis, acting to coordinate the activities of multiple tissues to generate heat.
EXPERIMENTAL PROCEDURES Antibodies
Antibodies were purchased from Santa Cruz Biotechnology (IRF4, sc-6059; actin, sc-1615; PGC-1a, sc-13067), Abcam (UCP1, AB10983; Mito profile, AB110413; Aconitase, AB110321), and Millipore (PGC-1a, ST1202-1SET).
Animals
Mice were maintained under a 12 hr light/12 hr dark cycle at constant temperature (23 C) with free access to food and water. All animal studies were approved by (E) Lipid handling and general adipose marker gene expression in BAT. RNA was harvested from BAT of BATI4KO or control littermates after 22 weeks on HFD. Gene expression was measured using qPCR. Data are normalized to 36B4 and expressed as mean ± SEM (n = 3-5, *p < 0.05). C or 4 C for 6 hr. Gene expression was measured using qPCR.
Data are normalized to 36B4 and expressed as mean ± SEM (n = 3-5, *, versus WT RT, p < 0.05; #, versus WT cold, p < 0.05).
(B) Mice were treated with CL316,423 or saline for 6 hr and BAT was harvested. Gene expression was analyzed by qPCR. Data are normalized to 36B4 and expressed as mean ± SEM (n = 3-5, *, versus WT saline, p < 0.05; #, versus WT CL, p < 0.05).
the Institutional Animal Care and Use Committee of Beth Israel Deaconess Medical Center. For determination of IRF4 expression in fat depots from mice exposed to cold, mice were housed at 4 C for up to 6 days. The 16-week-old ob/ob and db/db mice were purchased from Jackson Laboratories. For DIO studies, C57BL/6J mice were fed an HFD (D12331; Research Diets) for 12 weeks.
Cold-Induced Thermogenesis
Mice were placed in a cold chamber (4 C) for up to 1 week. Body temperature was measured using a rectal probe (Yellow Spring Instruments). 
Indirect Calorimetry
Glucose and Insulin Tolerance Tests
For glucose tolerance tests (GTTs), mice were fasted overnight. Glucose (2 g/kg) was administered intraperitoneally (i.p.), and blood glucose levels were measured at 0, 15, 30, 60, and 120 min. Serum insulin was measured during the GTT at the 0, 15, and 60 min time points. For the insulin tolerance test (ITT), mice were fasted for 6 hr. Insulin (0.7 U/kg for chow diet and 0.8 U/kg for HFD) was administered i.p., and blood glucose was measured at 0, 15, 30, 60, and 120 min.
Determination of Cellular Respiration
Tissue respiration was performed using a Clark electrode (Strathkelvin Instruments). Freshly isolated BAT was isolated, rinsed in sterile saline, weighed, minced, and placed into respiration buffer, and readings were taken with three separate pieces of tissue of equivalent size. Oxygen consumption was normalized to tissue weight. For Seahorse studies, BAT mitochondria were isolated in STE buffer, pH 7.4 (250 mM sucrose, 5 mM Tris, 2 mM EGTA). Mitochondria were resuspended in assay buffer (50 mM KCl, 4 mM KH 2 PO4, 5 mM HEPES, and 1 mM EGTA, 4% BSA, 10 mM Pyruvate, 5 mM Malate). Oxygen consumption rate (OCR) of BAT mitochondria (5 mg) was determined using an XF24 Extracellular Flux Analyzer (Seahorse Bioscience). Uncoupled and maximal OCR was determined using oligomycin (14 mM) and FCCP (10 mM). Antimycin A and rotenone (4 mM each) were used to inhibit Complex III-and Complex I-dependent respiration.
Luciferase Reporter Assays
The mouse Ucp1 promoter was amplified and inserted into the KpnI and XhoI sites of pGL3-basic (Promega). HEK293T cells were cultured in 24-well plates and cotransfected with PGC-1a plasmid (0.2 mg/well), IRF4 plasmid (0.2 mg/ well), luciferase reporter construct (0.2 mg/well), and galactosidase expression vector (control reporter) (0.006 mg/well) with the Profection kit (Promega), according to the manufacturer's protocol. The mass of transfected plasmids was balanced with empty vector (pCDH-EGFP). After 48 hr, cells were harvested and measured using the Dual-Luciferase Reporter assay system (Promega), and luciferase activity was divided by Renilla luciferase activity (control reporter) to normalize for transfection efficiency. Alternatively, SVFs were extracted from BAT and then 6 days after adipogenic stimulation, adipocytes were detached with trypsin and transfected using the Amaxa nucleofection system (Amaxa Biosystems). Transfections were performed with 1 mg reporter construct along with 0.5 mg IRF4-pCDH expression vector, 1 mg pcDNA-PGC-1a, with 25 ng galactosidase expression vector. After 48 hr, cells were harvested and measured using the Dual-Luciferase Reporter assay system (Promega). All luciferase assay experiments were performed three times at least and each conducted in triplicate.
Chromatin Immunoprecipitation
Nuclei were extracted from BAT of BATI4OE mice and then treated with 1% formaldehyde for 4 min at room temperature to crosslink DNA-protein complexes. Genomic DNA was sheared with a Sonic Dismembrator Model 100 (Fisher Scientific) to obtain fragments ranging from 200 bp to 1 kb. Chromatin immunoprecipitation (ChIP) was performed with a kit from Upstate, with 10 mg primary antibody from Santa Cruz (goat anti-iRF4; sc-6059) or goat IgG. Crosslinking was reversed, and purified DNA was subjected to qPCR with SYBR green fluorescent dye (Stratagene).
Protein Extraction and Western Blot Analysis
Protein was extracted from BAT by using RIPA buffer (Boston BioProducts) supplemented with complete protease inhibitor cocktail (Roche). For western blot analyses, 60 mg protein was subjected to SDS-PAGE under reducing conditions, transferred, and blotted with an appropriate antibody.
Coimmunoprecipitation Studies HEK293T cells were transfected with IRF4, PGC-1a, or both. Cell lysates were collected in RIPA buffer 48 hr after transfection. IRF4 protein was immunoprecipitated using anti-iRF4 antibody (sc-28696; Santa Cruz). IRF4 was western blotted using anti-iRF4 antibody (sc-6059; Santa Cruz) and anti-PGC-1a antibody (AB3242; Millipore).
GST-Pull-Down GST-PGC-1a vector was a gift from Pere Puigserver and was transformed into BL21 (NEB) to express the protein. IRF4 was synthesized using a TNT-coupled in vitro transcription/translation system (Promega). The resultant protein was incubated with GST-PGC-1a and then immobilized on glutathione-Sepharose beads according to the manufacturer's instructions (Thermo). Proteins were eluted by glutathione and analyzed by western blotting.
Analysis of Gene Expression by qPCR
Total RNA was extracted from tissues with TRIzol reagent (Invitrogen) according to the manufacturer's instructions. 1 mg total RNA was converted into firststrand cDNA with oligo(dT) primers as described by the manufacturer (Clontech). PCR was performed in an Mx3000P Q-PCR system (Stratagene) with specific primers and SYBR Green PCR Master Mix (Stratagene). The relative abundance of mRNAs was standardized with 36B4 mRNA as the invariant control.
Adenovirus Production, Purification, and Injection The adenoviral expression vector pAD/CMV/V5-DEST (Invitrogen) encoding cDNA for PGC-1a and Lac Z were constructed as per manufacturer's protocol. Crude adenovirus were amplified twice and then purified using the Vivapure adenopack-100 purification kit (Sartorius Stedim). Adenovirus titer was calculated using Adeno-X Rapid Titer kit (Clontech). For fat pad injections, Lac Z or PGC-1a adenovirus (1 3 10 10 infectious units/mice) were injected subcutaneously into the inguinal fat pad in a total volume of 50 ml.
Statistical Analysis
Unpaired two-tailed Student's t tests and two-way ANOVA were used. p < 0.05 was considered statistically significant. 
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